These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 39366755)

  • 1. 5-Hydroxymethylcytosine in circulating cell-free DNA as a potential diagnostic biomarker for SLE.
    Tong X; Chen W; Ye L; Xiong Y; Xu Y; Luo Y; Xia X; Xu Z; Lin Y; Zhu X; Wang N; Xue X; Zhang H; Guo G
    Lupus Sci Med; 2024 Oct; 11(2):. PubMed ID: 39366755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
    Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D
    J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the Genomic Distribution of 5hmC in In Vivo Aged Human Skin Fibroblasts.
    Kołodziej-Wojnar P; Borkowska J; Wicik Z; Domaszewska-Szostek A; Połosak J; Cąkała-Jakimowicz M; Bujanowska O; Puzianowska-Kuznicka M
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
    Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
    Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease.
    Dong C; Chen J; Zheng J; Liang Y; Yu T; Liu Y; Gao F; Long J; Chen H; Zhu Q; He Z; Hu S; He C; Lin J; Tang Y; Zhu H
    Clin Epigenetics; 2020 Jan; 12(1):17. PubMed ID: 31964422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
    Gao P; Lin S; Cai M; Zhu Y; Song Y; Sui Y; Lin J; Liu J; Lu X; Zhong Y; Cui Y; Zhou P
    J Cell Mol Med; 2019 May; 23(5):3530-3537. PubMed ID: 30912288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.
    Song CX; Yin S; Ma L; Wheeler A; Chen Y; Zhang Y; Liu B; Xiong J; Zhang W; Hu J; Zhou Z; Dong B; Tian Z; Jeffrey SS; Chua MS; So S; Li W; Wei Y; Diao J; Xie D; Quake SR
    Cell Res; 2017 Oct; 27(10):1231-1242. PubMed ID: 28820176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
    Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
    Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma.
    Liu H; Xu T; Cheng Y; Jin MH; Chang MY; Shu Q; Allen EG; Jin P; Wang X
    DNA Cell Biol; 2019 Dec; 38(12):1460-1469. PubMed ID: 31657619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
    Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
    Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus.
    Zhao M; Wang J; Liao W; Li D; Li M; Wu H; Zhang Y; Gershwin ME; Lu Q
    J Autoimmun; 2016 May; 69():64-73. PubMed ID: 26984631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide characterization of dynamic DNA 5-hydroxymethylcytosine and TET2-related DNA demethylation during breast tumorigenesis.
    Wu SL; Yang L; Huang C; Li Q; Ma C; Yuan F; Zhou Y; Wang X; Tong WM; Niu Y; Jin F
    Clin Epigenetics; 2024 Sep; 16(1):125. PubMed ID: 39261937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxymethylcytosines in circulating cell-free DNA as a diagnostic biomarker for nasopharyngeal carcinoma.
    Chen B; Wang D; Xu Y; Guo Q; Pan J; Yu S; Fang Y; Xiao S; Ruan Y; Yang S; Lin M; Hong J; Zhan Z; Lin S
    Eur J Cancer; 2024 Oct; 210():114294. PubMed ID: 39213787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in 5hmC level and genomic distribution in aging-related epigenetic drift in human adipose stem cells.
    Borkowska J; Domaszewska-Szostek A; Kołodziej P; Wicik Z; Połosak J; Buyanovskaya O; Charzewski L; Stańczyk M; Noszczyk B; Puzianowska-Kuznicka M
    Epigenomics; 2020 Mar; 12(5):423-437. PubMed ID: 32031421
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    West-Szymanski DC; Zhang Z; Cui XL; Kowitwanich K; Gao L; Deng Z; Dougherty U; Williams C; Merkle S; He C; Zhang W; Bissonnette M
    JCO Precis Oncol; 2024 Oct; 8():e2400277. PubMed ID: 39393034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer.
    Zhang J; Han X; Gao C; Xing Y; Qi Z; Liu R; Wang Y; Zhang X; Yang YG; Li X; Sun B; Tian X
    Genomics Proteomics Bioinformatics; 2018 Jun; 16(3):187-199. PubMed ID: 30010036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical Applications.
    Li JJN; Liu G; Lok BH
    Genes (Basel); 2024 Sep; 15(9):. PubMed ID: 39336751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.
    Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E
    Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.
    Alberge JB; Magrangeas F; Wagner M; Denié S; Guérin-Charbonnel C; Campion L; Attal M; Avet-Loiseau H; Carell T; Moreau P; Minvielle S; Sérandour AA
    Clin Epigenetics; 2020 Nov; 12(1):163. PubMed ID: 33138842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free DNA 5-hydroxymethylcytosine profiles of long non-coding RNA genes enable early detection and progression monitoring of human cancers.
    Zhou M; Hou P; Yan C; Chen L; Li K; Wang Y; Zhao J; Su J; Sun J
    Clin Epigenetics; 2021 Oct; 13(1):197. PubMed ID: 34689838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.